Immage Biotherapeutics Corp.
OTC: IMMG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- CEO
- Zhi Cong Mou
- Employees
- 3
- Headquarters
- Bethesda, United States
- IPO year
- 2022
- Market cap
- $15.2K
- Website
- https://www.immagebio.com
Loading IMMG…
Loading profile data…Frequently asked questions about IMMG
What does Immage Biotherapeutics Corp. (IMMG) do?
Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherap...
Where does IMMG trade?
Immage Biotherapeutics Corp. (IMMG) trades on the Other OTC.
What sector is IMMG in?
Immage Biotherapeutics Corp. (IMMG) operates in the Financial Services sector, specifically in the Financial - Conglomerates industry.
Who is the CEO of Immage Biotherapeutics Corp.?
Zhi Cong Mou is the chief executive officer of Immage Biotherapeutics Corp. (IMMG).
Where is Immage Biotherapeutics Corp. headquartered?
Immage Biotherapeutics Corp. is headquartered in United States.
Does IMMG pay a dividend?
Immage Biotherapeutics Corp. (IMMG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IMMG go public?
Immage Biotherapeutics Corp. (IMMG) completed its initial public offering in 2022.